Lavipharm S.A. (ATH:LAVI)
Greece · Delayed Price · Currency is EUR 1.578
+0.014 (0.90%)
Sep 23, 2026, 5:09 PM EET
Lavipharm Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 70.32 | 62.58 | 52.95 | 47.84 | 39.06 | 39.72 |
Revenue Growth | 28.64% | 18.20% | 10.68% | 22.48% | -1.68% | 5.54% |
Gross Profit Gross Profit Growth | 33.15 | 30.31 | 25.08 | 22.15 | 17.62 | 15.89 |
Operating Income Operating Income Growth | 8.91 | 8.62 | 5.03 | 4.72 | 4.07 | 4.51 |
Net Income Net Income Growth | 5.74 | 5.99 | 8.98 | 1.87 | 0.83 | 1.72 |
Earnings Per Share EPS Growth | 0.03 | 0.03 | 0.05 | 0.01 | 0.04 | 0.10 |
EPS Growth | 43.13% | -34.71% | 379.94% | -71.35% | -61.71% | -17.72% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Greece Greece Growth | 38.81 | 28.44 | 21.55 | 31.18 | 27.58 |
European Union European Union Growth | 17.62 | 18.83 | 22.75 | 12.2 | 10.41 |
Other countries Other countries Growth | 6.15 | 5.68 | 3.55 | 2.62 | 1.73 |
Total Total Growth | 62.58 | 52.95 | 47.84 | 46.01 | 39.72 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.62 | 6.11 | 5.59 | 8.44 | 18.24 | 1.64 |
Total Debt Total Debt Growth | 41.28 | 32.78 | 33.92 | 32.48 | 37.18 | 37.33 |
Net Cash (Debt) Net Cash Growth | -37.66 | -26.67 | -28.34 | -24.04 | -18.93 | -35.69 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.22 | -0.16 | -0.17 | -0.14 | -0.88 | -2.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 7.13 | 6.66 | 4.5 | 0.28 | 3.35 | 4.11 |
Capital Expenditures CapEx Growth | -12.13 | -1.27 | -9.64 | -4.05 | -35.62 | -1.92 |
Free Cash Flow Free Cash Flow Growth | -5 | 5.39 | -5.15 | -3.77 | -32.27 | 2.19 |
Free Cash Flow Growth | - | - | - | - | - | 59.53% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.14% | 48.43% | 47.37% | 46.30% | 45.12% | 40.00% |
Operating Margin | 12.67% | 13.78% | 9.50% | 9.86% | 10.41% | 11.35% |
Pretax Margin | 11.09% | 11.99% | 6.81% | 6.73% | 5.78% | 6.92% |
Profit Margin | 8.17% | 9.56% | 16.96% | 3.91% | 2.14% | 4.34% |
FCF Margin | -7.11% | 8.62% | -9.72% | -7.87% | -82.63% | 5.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.020 | 0.020 | 0.020 |
Dividend Per Share Growth | 0% | 0% | - |
Dividend Yield | 1.27% | 2.09% | 2.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 47.66 | 27.34 | 14.93 | 71.42 | 77.29 | 17.20 |
P/FCF Ratio | - | 30.35 | - | - | - | 13.52 |
PS Ratio | 3.80 | 2.62 | 2.53 | 2.79 | 1.65 | 0.75 |